These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 1729364)

  • 1. A lipoyl synthetic octadecapeptide of dihydrolipoamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis.
    Tuaillon N; Andre C; Briand JP; Penner E; Muller S
    J Immunol; 1992 Jan; 148(2):445-50. PubMed ID: 1729364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex.
    Fregeau DR; Davis PA; Danner DJ; Ansari A; Coppel RL; Dickson ER; Gershwin ME
    J Immunol; 1989 Jun; 142(11):3815-20. PubMed ID: 2715637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative epitope mapping of murine monoclonal and human autoantibodies to human PDH-E2, the major mitochondrial autoantigen of primary biliary cirrhosis.
    Surh CD; Ahmed-Ansari A; Gershwin ME
    J Immunol; 1990 Apr; 144(7):2647-52. PubMed ID: 1690773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and disease associated autoantibodies to the autoantigen, dihydrolipoamide acetyltransferase, recognise different epitopes.
    Chen QY; Mackay IR; Fida S; Myers MA; Rowley MJ
    J Autoimmun; 1998 Apr; 11(2):151-61. PubMed ID: 9650094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.
    Dubel L; Tanaka A; Leung PS; Van de Water J; Coppel R; Roche T; Johanet C; Motokawa Y; Ansari A; Gershwin ME
    Hepatology; 1999 Apr; 29(4):1013-8. PubMed ID: 10094940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
    Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME
    Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactivity of porcine heart dihydrolipoamide acetyl- and succinyl-transferases (PDC-E2, OGDC-E2) with primary biliary cirrhosis sera: characterization of the autoantigenic region and effects of enzymatic delipoylation and relipoylation.
    Koike K; Ishibashi H; Koike M
    Hepatology; 1998 Jun; 27(6):1467-74. PubMed ID: 9620315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple autoepitope presentation for specific detection of antibodies in primary biliary cirrhosis.
    Briand JP; Andre C; Tuaillon N; Herve L; Neimark J; Muller S
    Hepatology; 1992 Dec; 16(6):1395-403. PubMed ID: 1280244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope.
    Surh CD; Coppel R; Gershwin ME
    J Immunol; 1990 May; 144(9):3367-74. PubMed ID: 1691756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis.
    Miyakawa H; Tanaka A; Selmi C; Hosoya N; Mataki N; Kikuchi K; Kato T; Arai J; Goto T; Gershwin ME
    Clin Dev Immunol; 2006; 13(2-4):289-94. PubMed ID: 17162370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display.
    Ikuno N; Scealy M; Davies JM; Whittingham SF; Omagari K; Mackay IR; Rowley MJ
    Hepatology; 2001 Sep; 34(3):478-86. PubMed ID: 11526532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment.
    Quinn J; Diamond AG; Palmer JM; Bassendine MF; James OF; Yeaman SJ
    Hepatology; 1993 Dec; 18(6):1384-91. PubMed ID: 7694896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic.
    Migliaccio C; Van de Water J; Ansari AA; Kaplan MM; Coppel RL; Lam KS; Thompson RK; Stevenson F; Gershwin ME
    Hepatology; 2001 Apr; 33(4):792-801. PubMed ID: 11283841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution to antimitochondrial antibody production: cleavage of pyruvate dehydrogenase complex-E2 by apoptosis-related proteases.
    Matsumura S; Van De Water J; Kita H; Coppel RL; Tsuji T; Yamamoto K; Ansari AA; Gershwin ME
    Hepatology; 2002 Jan; 35(1):14-22. PubMed ID: 11786955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.
    Moteki S; Leung PS; Dickson ER; Van Thiel DH; Galperin C; Buch T; Alarcon-Segovia D; Kershenobich D; Kawano K; Coppel RL
    Hepatology; 1996 Mar; 23(3):436-44. PubMed ID: 8617422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary biliary cirrhosis. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1 alpha, a non-lipoic acid containing mitochondrial enzyme.
    Fregeau DR; Roche TE; Davis PA; Coppel R; Gershwin ME
    J Immunol; 1990 Mar; 144(5):1671-6. PubMed ID: 2106552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.
    Nishio A; Van de Water J; Leung PS; Joplin R; Neuberger JM; Lake J; Björkland A; Tötterman TH; Peters M; Worman HJ; Ansari AA; Coppel RL; Gershwin ME
    Hepatology; 1997 May; 25(5):1085-9. PubMed ID: 9141421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: searching for a mimic.
    Sasaki M; Ansari A; Pumford N; van de Water J; Leung PS; Humphries KM; Szweda LI; Nakanuma Y; Roche TE; Coppel RL; Bach JF; Gershwin ME
    J Autoimmun; 2000 Aug; 15(1):51-60. PubMed ID: 10936028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope.
    Leung PS; Chuang DT; Wynn RM; Cha S; Danner DJ; Ansari A; Coppel RL; Gershwin ME
    Hepatology; 1995 Aug; 22(2):505-13. PubMed ID: 7543435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PDC-E2 human combinatorial autoantibodies by peptide mimotopes.
    Leung PS; Cha S; Joplin RE; Galperin C; Van de Water J; Ansari AA; Coppel RL; Schatz PJ; Cwirla S; Fabris LE; Neuberger JM; Gershwin ME
    J Autoimmun; 1996 Dec; 9(6):785-93. PubMed ID: 9115581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.